Sonia Lacroix-Lamandé
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sonia Lacroix-Lamandé has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Fabrice Laurent
INRAE, Université François Rabelais de Tours, Centre Val de Loire, UMR1282 ISP, Laboratoire Apicomplexes et Immunité Mucosale, 37380 Nouzilly, France
4 shared publications Tiffany Pezier
INRAE, Université de Tours, UMR 1282 Infectiologie et Santé Publique, Laboratoire AIM Nouzilly France
4 shared publications- Anne Silvestre
INRAE, UMR ISP, Université de Tours, Nouzilly 37380, France
3 shared publications - Mégane Fernandez
INRAE, Université de Tours, UMR 1282 Infectiologie et Santé Publique, Laboratoire BiapI, Nouzilly, France
3 shared publications Catherine Werts
Institut Pasteur, INSERM U1306, Unité de Biologie et Génétique de La Paroi Bactérienne Paris France
2 shared publications- Catherine Werts
Institut Pasteur
2 shared publications
Latest Publications
- Open Access
- 31 May 2026
- Published by SAGE Publications in Innate Immunity
- Vol. 32
Trained immunity agonists given to neonatal mice fail to protect against leptospiral infection in adulthood and may cause adverse effects
Background and Objectives: Trained immunity (TI) refers to a non-specific, long-lasting protective immune response that occurs following initial stimulation of the immune system and thought to be largely mediated by functional reprogramming of myeloid cells. TI has been demonstrated in BCG-vaccinated infants and can be induced in human cells and adult mice via agonists of pattern recognition receptors (PRR), such as β-glucan or MDP (a muropeptide that activates NOD2). However, its induction in neonates remains poorly understood. Previously, we demonstrated that the synthetic TLR2-NOD2 dual agonist CL429 enhances antimicrobial functions in adult mice and protects against subsequent infection with Leptospira interrogans , a zoonotic pathogen. We also demonstrated the immediate protective benefits of NOD2 stimulation in neonates against Cryptosporidium, a zoonotic pathogen that affects young animals in livestock herds. However, whether NOD2 agonists can induce TI in neonates and protect them at adulthood is unknown. Methods and Results: Here, we investigated whether exposure of neonatal mice to PRR agonists (CL429, MDP or β-glucan), administered intraperitoneally at one week interval at 7/14 or 14/21 days of age, could enhance inflammatory cytokines production after ex vivo restimulation and confer long-term protection into adulthood. Surprisingly, none of the treatments enhanced ex vivo cytokine responses in adulthood after restimulation, nor did they confer protection against experimental leptospirosis. Instead, MDP-treated neonates exhibited 50% mortality following adult infection, revealing an unexpected detrimental effect. Conclusion: These findings demonstrate that these PRR agonists fail to induce protective TI against Leptospira when administered to neonatal mice, challenging assumptions derived from adult models. Furthermore, our study reveals the risks of administering immunostimulants during the early stages of life, and highlights unanticipated and potentially harmful, PRR- and age-specific mechanisms of immune system modulation.
- 31 May 2026
- Published by SAGE Publications in Innate Immunity
- Vol. 32
Open AccessTrained immunity agonists given to neonatal mice fail to protect against leptospiral infection in adulthood and may cause adverse effects
Background and Objectives: Trained immunity (TI) refers to a non-specific, long-lasting protective immune response that occurs following initial stimulation of the immune system and thought to be largely mediated by functional reprogramming of myeloid cells. TI has been demonstrated in BCG-vaccinated infants and can be induced in human cells and adult mice via agonists of pattern recognition receptors (PRR), such as β-glucan or MDP (a muropeptide that activates NOD2). However, its induction in neonates remains poorly understood. Previously, we demonstrated that the synthetic TLR2-NOD2 dual agonist CL429 enhances antimicrobial functions in adult mice and protects against subsequent infection with Leptospira interrogans , a zoonotic pathogen. We also demonstrated the immediate protective benefits of NOD2 stimulation in neonates against Cryptosporidium, a zoonotic pathogen that affects young animals in livestock herds. However, whether NOD2 agonists can induce TI in neonates and protect them at adulthood is unknown. Methods and Results: Here, we investigated whether exposure of neonatal mice to PRR agonists (CL429, MDP or β-glucan), administered intraperitoneally at one week interval at 7/14 or 14/21 days of age, could enhance inflammatory cytokines production after ex vivo restimulation and confer long-term protection into adulthood. Surprisingly, none of the treatments enhanced ex vivo cytokine responses in adulthood after restimulation, nor did they confer protection against experimental leptospirosis. Instead, MDP-treated neonates exhibited 50% mortality following adult infection, revealing an unexpected detrimental effect. Conclusion: These findings demonstrate that these PRR agonists fail to induce protective TI against Leptospira when administered to neonatal mice, challenging assumptions derived from adult models. Furthermore, our study reveals the risks of administering immunostimulants during the early stages of life, and highlights unanticipated and potentially harmful, PRR- and age-specific mechanisms of immune system modulation.
- Open Access
- 7 May 2026
- Published by Walter de Gruyter GmbH in Biological Chemistry
- Vol. 407 (7-9) , 425-452
Cysteine cathepsin proteases in apicomplexan parasites
Cysteine cathepsins are papain-like proteases which play key roles in a large range of organisms, including apicomplexan parasites. These obligate endoparasites are responsible for many devastating diseases in human and/or animal hosts, for which available treatments are limited or face the emergence of resistance. This review presents the cysteine cathepsins expressed by five major Apicomplexa ( Plasmodium falciparum , Cryptosporidium parvum , Toxoplasma gondii , Eimeria tenella and Babesia bovis ), highlighting available data on their structures, specific or common features, and biological functions in the parasite biology and host-parasite interactions. Although they belong to the same phylum, apicomplexan parasites have very distinct life cycles and biology, which are well adapted to the hosts they infect and to the tissues within which they develop. Accordingly, apicomplexan cysteine cathepsins display a wide variety of functions, associated with shared (e.g., invasion of and egress from host cells) or unique (e.g., degradation of haemoglobin in P. falciparum ) biological pathways. Through their crucial functions and involvement in multiple parasite stages, these parasitic proteases represent assumed therapeutic targets. The description of apicomplexan cysteine cathepsins also appears uneven within the phylum, and further exploration of their biology and role is needed to drive novel preventive or curative intervention strategies.
- 7 May 2026
- Published by Walter de Gruyter GmbH in Biological Chemistry
- Vol. 407 (7-9) , 425-452
Open AccessCysteine cathepsin proteases in apicomplexan parasites
Cysteine cathepsins are papain-like proteases which play key roles in a large range of organisms, including apicomplexan parasites. These obligate endoparasites are responsible for many devastating diseases in human and/or animal hosts, for which available treatments are limited or face the emergence of resistance. This review presents the cysteine cathepsins expressed by five major Apicomplexa ( Plasmodium falciparum , Cryptosporidium parvum , Toxoplasma gondii , Eimeria tenella and Babesia bovis ), highlighting available data on their structures, specific or common features, and biological functions in the parasite biology and host-parasite interactions. Although they belong to the same phylum, apicomplexan parasites have very distinct life cycles and biology, which are well adapted to the hosts they infect and to the tissues within which they develop. Accordingly, apicomplexan cysteine cathepsins display a wide variety of functions, associated with shared (e.g., invasion of and egress from host cells) or unique (e.g., degradation of haemoglobin in P. falciparum ) biological pathways. Through their crucial functions and involvement in multiple parasite stages, these parasitic proteases represent assumed therapeutic targets. The description of apicomplexan cysteine cathepsins also appears uneven within the phylum, and further exploration of their biology and role is needed to drive novel preventive or curative intervention strategies.
- Open Access
- 12 April 2026
- Published by Elsevier in International Journal for Parasitology: Drugs and Drug Resistance
- Vol. 31, 100642
Terpenic compounds possess anthelmintic and immunomodulatory properties with potential for controlling equine cyathostomin infections
- 12 April 2026
- Published by Elsevier in International Journal for Parasitology: Drugs and Drug Resistance
- Vol. 31, 100642
Open AccessTerpenic compounds possess anthelmintic and immunomodulatory properties with potential for controlling equine cyathostomin infections
- Open Access
- 20 October 2025
- Published by Wiley in European Journal of Immunology
- Vol. 55 (10) , e70080
Administration of the NOD2 Agonist MDP Reduces Cryptosporidium parvum Infection in Neonatal Mice Through IL‐22 Involvement
At birth, the mucosal immune system of neonates is not fully developed, making them more susceptible to respiratory and intestinal diseases. Previously described host‐directed therapies using toll‐like receptor (TLR) activation‐based strategies have proven effective in controlling neonatal diseases, including cryptosporidiosis. In this study, we investigated the effect of nucleotide‐binding oligomerization domain (NOD) receptors stimulation on the control of enteric infection by the protozoan Cryptosporidium parvum in neonatal mice. NOD2 stimulation by intraperitoneal injection of muramyl dipeptide (MDP) resulted in a rapid reduction in the parasite burden. The protective effect was associated with increased pro‐inflammatory cytokine and antimicrobial peptide gene expression and a rapid influx of neutrophils to the site of infection, whereas NOD1 stimulation did not show a protective effect. The protective mechanism did not involve microbiota participation but involved IFN‐γ and IL‐22 cytokines and was associated with increased intestinal epithelium renewal in infected neonates. Our findings showed that stimulating neonatal mice with the bacterial ligand MDP, which targets the NOD2 receptor, actively contributes to the nonspecific clearance of C. parvum infection by eliminating or renewing infected epithelial cells.
- 20 October 2025
- Published by Wiley in European Journal of Immunology
- Vol. 55 (10) , e70080
Open AccessAdministration of the NOD2 Agonist MDP Reduces Cryptosporidium parvum Infection in Neonatal Mice Through IL‐22 Involvement
At birth, the mucosal immune system of neonates is not fully developed, making them more susceptible to respiratory and intestinal diseases. Previously described host‐directed therapies using toll‐like receptor (TLR) activation‐based strategies have proven effective in controlling neonatal diseases, including cryptosporidiosis. In this study, we investigated the effect of nucleotide‐binding oligomerization domain (NOD) receptors stimulation on the control of enteric infection by the protozoan Cryptosporidium parvum in neonatal mice. NOD2 stimulation by intraperitoneal injection of muramyl dipeptide (MDP) resulted in a rapid reduction in the parasite burden. The protective effect was associated with increased pro‐inflammatory cytokine and antimicrobial peptide gene expression and a rapid influx of neutrophils to the site of infection, whereas NOD1 stimulation did not show a protective effect. The protective mechanism did not involve microbiota participation but involved IFN‐γ and IL‐22 cytokines and was associated with increased intestinal epithelium renewal in infected neonates. Our findings showed that stimulating neonatal mice with the bacterial ligand MDP, which targets the NOD2 receptor, actively contributes to the nonspecific clearance of C. parvum infection by eliminating or renewing infected epithelial cells.
- Open Access
NOD2 stimulation reduces Cryptosporidium parvum level of infection in neonates by promoting intestinal epithelial production of antimicrobial peptides and cell renewing
At birth, the mucosal immune system of neonates is not fully developed, making them more susceptible to respiratory and intestinal diseases. Previously described host-directed therapies using TLR activation-based strategies have proven effective in controlling neonatal diseases, including cryptosporidiosis. In this study, we investigated the effect of NOD receptor stimulation on the control of enteric infection by the protozoan Cryptosporidium parvum in neonatal mice. NOD2 stimulation by intraperitoneal injection of MDP resulted in a rapid reduction in the parasite burden. The protective effect was associated with increased proinflammatory cytokine and antimicrobial peptide gene expression and a rapid influx of neutrophils to the site of infection, whereas NOD1 stimulation did not show a protective effect. The protective mechanism did not involve microbiota participation but involved IFN-γ and IL-22 cytokines and was associated with increased intestinal epithelium renewal in infected neonates. Our findings, demonstrated in neonatal mice, elucidate how the stimulation of NOD2 with the bacterial ligand MDP actively contributes to the non-specific clearance of a parasitic infection within the intestinal epithelial cells. Author Summary: Newborns are particularly vulnerable to intestinal infections due to their immature immune systems. Developing strategies to enhance their ability to fight infections is crucial for improving neonatal health. In this study, we investigated how stimulation of a specific immune receptor, NOD2, can help neonatal mice control an intestinal infection caused by the protozoan Cryptosporidium parvum. We found that intraperitoneally administration of a bacterial molecule called MDP, which activates the NOD2 receptor, led to a rapid reduction in the parasite burden. This protection was associated with increased production of inflammatory molecules, antimicrobial peptides, and a significant influx of neutrophils to the site of infection. Importantly, the protective effect did not depend on the gut microbiota but involved specific immune signals, such as IFN-γ and IL-22, and enhanced the renewal of intestinal epithelial cells. These findings highlight how targeting NOD2 can boost neonatal innate immunity, offering a potential host-directed strategy to combat severe intestinal infections, limit long-term intestinal damage and reduce the risk of fatal outcomes.
Open AccessNOD2 stimulation reduces Cryptosporidium parvum level of infection in neonates by promoting intestinal epithelial production of antimicrobial peptides and cell renewing
At birth, the mucosal immune system of neonates is not fully developed, making them more susceptible to respiratory and intestinal diseases. Previously described host-directed therapies using TLR activation-based strategies have proven effective in controlling neonatal diseases, including cryptosporidiosis. In this study, we investigated the effect of NOD receptor stimulation on the control of enteric infection by the protozoan Cryptosporidium parvum in neonatal mice. NOD2 stimulation by intraperitoneal injection of MDP resulted in a rapid reduction in the parasite burden. The protective effect was associated with increased proinflammatory cytokine and antimicrobial peptide gene expression and a rapid influx of neutrophils to the site of infection, whereas NOD1 stimulation did not show a protective effect. The protective mechanism did not involve microbiota participation but involved IFN-γ and IL-22 cytokines and was associated with increased intestinal epithelium renewal in infected neonates. Our findings, demonstrated in neonatal mice, elucidate how the stimulation of NOD2 with the bacterial ligand MDP actively contributes to the non-specific clearance of a parasitic infection within the intestinal epithelial cells. Author Summary: Newborns are particularly vulnerable to intestinal infections due to their immature immune systems. Developing strategies to enhance their ability to fight infections is crucial for improving neonatal health. In this study, we investigated how stimulation of a specific immune receptor, NOD2, can help neonatal mice control an intestinal infection caused by the protozoan Cryptosporidium parvum. We found that intraperitoneally administration of a bacterial molecule called MDP, which activates the NOD2 receptor, led to a rapid reduction in the parasite burden. This protection was associated with increased production of inflammatory molecules, antimicrobial peptides, and a significant influx of neutrophils to the site of infection. Importantly, the protective effect did not depend on the gut microbiota but involved specific immune signals, such as IFN-γ and IL-22, and enhanced the renewal of intestinal epithelial cells. These findings highlight how targeting NOD2 can boost neonatal innate immunity, offering a potential host-directed strategy to combat severe intestinal infections, limit long-term intestinal damage and reduce the risk of fatal outcomes.
- 14 June 2024
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 116 (5) , 1142-1156
Deleterious intestinal inflammation in neonatal mice treated with TLR2/TLR6 agonists
By providing innate immune modulatory stimuli, the early-life immune system can be enhanced to increase resistance to infections. Activation of innate cell surface receptors called pattern recognition receptors by Toll-like receptor (TLR) ligands is one promising approach that can help to control infections as described for listeriosis and cryptosporidiosis. In this study, the effect of TLR2/TLR1 and TLR2/TLR6 agonists was compared when injected into neonatal mice. Surprisingly, the stimulation of TLR2/TLR6 led to the death of the neonatal mice, which was not observed in adult mice. The TLR2/TLR6 agonist administration induced higher systemic and intestinal inflammation in both adult and neonatal mice when compared with TLR2/TLR1 agonist. The mortality of neonatal mice was interferon γ dependent and involved the intestinal production of interleukin-22 and interleukin-17A. This study clearly demonstrates that targeting TLRs as new control strategy of neonatal infections has to be used with caution. Depending on its heterodimeric form, TLR2 stimulation can induce more or less severe adverse effects relying on the age-related immune functions of the host.
- 14 June 2024
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 116 (5) , 1142-1156
Deleterious intestinal inflammation in neonatal mice treated with TLR2/TLR6 agonists
By providing innate immune modulatory stimuli, the early-life immune system can be enhanced to increase resistance to infections. Activation of innate cell surface receptors called pattern recognition receptors by Toll-like receptor (TLR) ligands is one promising approach that can help to control infections as described for listeriosis and cryptosporidiosis. In this study, the effect of TLR2/TLR1 and TLR2/TLR6 agonists was compared when injected into neonatal mice. Surprisingly, the stimulation of TLR2/TLR6 led to the death of the neonatal mice, which was not observed in adult mice. The TLR2/TLR6 agonist administration induced higher systemic and intestinal inflammation in both adult and neonatal mice when compared with TLR2/TLR1 agonist. The mortality of neonatal mice was interferon γ dependent and involved the intestinal production of interleukin-22 and interleukin-17A. This study clearly demonstrates that targeting TLRs as new control strategy of neonatal infections has to be used with caution. Depending on its heterodimeric form, TLR2 stimulation can induce more or less severe adverse effects relying on the age-related immune functions of the host.
- Open Access
- 2 May 2024
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1379798
Characterization of intestinal mononuclear phagocyte subsets in young ruminants at homeostasis and during Cryptosporidium parvum infection
Introduction: Cryptosporidiosis is a poorly controlled zoonosis caused by an intestinal parasite, Cryptosporidium parvum, with a high prevalence in livestock (cattle, sheep, and goats). Young animals are particularly susceptible to this infection due to the immaturity of their intestinal immune system. In a neonatal mouse model, we previously demonstrated the importance of the innate immunity and particularly of type 1 conventional dendritic cells (cDC1) among mononuclear phagocytes (MPs) in controlling the acute phase of C. parvum infection. These immune populations are well described in mice and humans, but their fine characterization in the intestine of young ruminants remained to be further explored.Methods: Immune cells of the small intestinal Peyer’s patches and of the distal jejunum were isolated from naive lambs and calves at different ages. This was followed by their fine characterization by flow cytometry and transcriptomic analyses (q-RT-PCR and single cell RNAseq (lamb cells)). Newborn animals were infected with C. parvum, clinical signs and parasite burden were quantified, and isolated MP cells were characterized by flow cytometry in comparison with age matched control animals.Results: Here, we identified one population of macrophages and three subsets of cDC (cDC1, cDC2, and a minor cDC subset with migratory properties) in the intestine of lamb and calf by phenotypic and targeted gene expression analyses. Unsupervised single-cell transcriptomic analysis confirmed the identification of these four intestinal MP subpopulations in lamb, while highlighting a deeper diversity of cell subsets among monocytic and dendritic cells. We demonstrated a weak proportion of cDC1 in the intestine of highly susceptible newborn lambs together with an increase of these cells within the first days of life and in response to the infection.Discussion: Considering cDC1 importance for efficient parasite control in the mouse model, one may speculate that the cDC1/cDC2 ratio plays also a key role for the efficient control of C. parvum in young ruminants. In this study, we established the first fine characterization of intestinal MP subsets in young lambs and calves providing new insights for comparative immunology of the intestinal MP system across species and for future investigations on host–Cryptosporidium interactions in target species.
- 2 May 2024
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1379798
Open AccessCharacterization of intestinal mononuclear phagocyte subsets in young ruminants at homeostasis and during Cryptosporidium parvum infection
Introduction: Cryptosporidiosis is a poorly controlled zoonosis caused by an intestinal parasite, Cryptosporidium parvum, with a high prevalence in livestock (cattle, sheep, and goats). Young animals are particularly susceptible to this infection due to the immaturity of their intestinal immune system. In a neonatal mouse model, we previously demonstrated the importance of the innate immunity and particularly of type 1 conventional dendritic cells (cDC1) among mononuclear phagocytes (MPs) in controlling the acute phase of C. parvum infection. These immune populations are well described in mice and humans, but their fine characterization in the intestine of young ruminants remained to be further explored.Methods: Immune cells of the small intestinal Peyer’s patches and of the distal jejunum were isolated from naive lambs and calves at different ages. This was followed by their fine characterization by flow cytometry and transcriptomic analyses (q-RT-PCR and single cell RNAseq (lamb cells)). Newborn animals were infected with C. parvum, clinical signs and parasite burden were quantified, and isolated MP cells were characterized by flow cytometry in comparison with age matched control animals.Results: Here, we identified one population of macrophages and three subsets of cDC (cDC1, cDC2, and a minor cDC subset with migratory properties) in the intestine of lamb and calf by phenotypic and targeted gene expression analyses. Unsupervised single-cell transcriptomic analysis confirmed the identification of these four intestinal MP subpopulations in lamb, while highlighting a deeper diversity of cell subsets among monocytic and dendritic cells. We demonstrated a weak proportion of cDC1 in the intestine of highly susceptible newborn lambs together with an increase of these cells within the first days of life and in response to the infection.Discussion: Considering cDC1 importance for efficient parasite control in the mouse model, one may speculate that the cDC1/cDC2 ratio plays also a key role for the efficient control of C. parvum in young ruminants. In this study, we established the first fine characterization of intestinal MP subsets in young lambs and calves providing new insights for comparative immunology of the intestinal MP system across species and for future investigations on host–Cryptosporidium interactions in target species.
- Open Access
- 13 September 2023
- Published by Universite de Bordeaux in INRAE Productions Animales
- Vol. 36 (2)
Les organoïdes intestinaux des animaux de rente : de nouveaux modèles de culture in vitro pour une meilleure compréhension du fonctionnement de l’intestin
L’intestin est un organe complexe aux fonctions multiples. En effet, il participe à la digestion et l'absorption des nutriments et protège l’individu des agressions par des agents pathogènes intestinaux en assurant un rôle de barrière. L’étude de ce compartiment digestif reste toutefois limitée par l’accès aux tissus que ce soit chez l’Homme ou l’animal. Dans ce contexte, le développement d’organoïdes intestinaux à partir de cellules souches représente une avancée technologique importante dans l’étude de la physiopathologie intestinale. De plus, cet outil permet de répondre à une demande sociétale visant à réduire l’usage d’animaux modèles pour la recherche et s’inscrit dans la démarche des 3Rs (Remplacement, Réduction et Raffinement).L’objectif de cette revue est, à partir de rappels de la fonction digestive, de faire un état des lieux sur les différents types d’organoïdes intestinaux existants dérivés d’animaux de rente et de discuter leurs avantages, leurs limites et surtout leur application.
- 13 September 2023
- Published by Universite de Bordeaux in INRAE Productions Animales
- Vol. 36 (2)
Open AccessLes organoïdes intestinaux des animaux de rente : de nouveaux modèles de culture in vitro pour une meilleure compréhension du fonctionnement de l’intestin
L’intestin est un organe complexe aux fonctions multiples. En effet, il participe à la digestion et l'absorption des nutriments et protège l’individu des agressions par des agents pathogènes intestinaux en assurant un rôle de barrière. L’étude de ce compartiment digestif reste toutefois limitée par l’accès aux tissus que ce soit chez l’Homme ou l’animal. Dans ce contexte, le développement d’organoïdes intestinaux à partir de cellules souches représente une avancée technologique importante dans l’étude de la physiopathologie intestinale. De plus, cet outil permet de répondre à une demande sociétale visant à réduire l’usage d’animaux modèles pour la recherche et s’inscrit dans la démarche des 3Rs (Remplacement, Réduction et Raffinement).L’objectif de cette revue est, à partir de rappels de la fonction digestive, de faire un état des lieux sur les différents types d’organoïdes intestinaux existants dérivés d’animaux de rente et de discuter leurs avantages, leurs limites et surtout leur application.
- Open Access
- 24 August 2021
- Published by MDPI AG in Veterinary Sciences
- Vol. 8 (9) , 170
Establishment of a Newborn Lamb Gut-Loop Model to Evaluate New Methods of Enteric Disease Control and Reduce Experimental Animal Use
Enteric infectious diseases are not all well controlled, which leads to animal suffering and sometimes death in the most severe cases, in addition to economic losses for farmers. Typical symptoms of enteric infections include watery diarrhea, stomach cramps or pain, dehydration, nausea, vomiting, fever and weight loss. Evaluation of new control methods against enteric infections requires the use of many animals. We aimed to develop a new method for an initial in vivo screen of promising compounds against neonatal diseases such as cryptosporidiosis while limiting experimental animal use. We therefore adapted an in vivo method of multiple consecutive but independent intestinal loops to newborn lambs delivered by cesarean section, in which endotoxin responsiveness is retained. This new method allowed for the screening of natural yeast fractions for their ability to stimulate immune responses and to limit early Cryptosporidium parvum development. This model may also be used to investigate host–pathogen interactions and immune responses in a neonatal controlled environment.
- 24 August 2021
- Published by MDPI AG in Veterinary Sciences
- Vol. 8 (9) , 170
Open AccessEstablishment of a Newborn Lamb Gut-Loop Model to Evaluate New Methods of Enteric Disease Control and Reduce Experimental Animal Use
Enteric infectious diseases are not all well controlled, which leads to animal suffering and sometimes death in the most severe cases, in addition to economic losses for farmers. Typical symptoms of enteric infections include watery diarrhea, stomach cramps or pain, dehydration, nausea, vomiting, fever and weight loss. Evaluation of new control methods against enteric infections requires the use of many animals. We aimed to develop a new method for an initial in vivo screen of promising compounds against neonatal diseases such as cryptosporidiosis while limiting experimental animal use. We therefore adapted an in vivo method of multiple consecutive but independent intestinal loops to newborn lambs delivered by cesarean section, in which endotoxin responsiveness is retained. This new method allowed for the screening of natural yeast fractions for their ability to stimulate immune responses and to limit early Cryptosporidium parvum development. This model may also be used to investigate host–pathogen interactions and immune responses in a neonatal controlled environment.
- Open Access
- 29 July 2021
- Published by MDPI AG in Microorganisms
- Vol. 9 (8) , 1621
Genome-Wide Expression Patterns of Rhoptry Kinases during the Eimeria tenella Life-Cycle
Kinome from apicomplexan parasites is composed of eukaryotic protein kinases and Apicomplexa specific kinases, such as rhoptry kinases (ROPK). Ropk is a gene family that is known to play important roles in host–pathogen interaction in Toxoplasma gondii but is still poorly described in Eimeria tenella, the parasite responsible for avian coccidiosis worldwide. In the E. tenella genome, 28 ropk genes are predicted and could be classified as active (n = 7), inactive (incomplete catalytic triad, n = 12), and non-canonical kinases (active kinase with a modified catalytic triad, n = 9). We characterized the ropk gene expression patterns by real-time quantitative RT-PCR, normalized by parasite housekeeping genes, during the E. tenella life-cycle. Analyzed stages were: non-sporulated oocysts, sporulated oocysts, extracellular and intracellular sporozoites, immature and mature schizonts I, first- and second-generation merozoites, and gametes. Transcription of all those predicted ropk was confirmed. The mean intensity of transcription was higher in extracellular stages and 7–9 ropk were specifically transcribed in merozoites in comparison with sporozoites. Transcriptional profiles of intracellular stages were closely related to each other, suggesting a probable common role of ROPKs in hijacking signaling pathways and immune responses in infected cells. These results provide a solid basis for future functional analysis of ROPK from E. tenella.
- 29 July 2021
- Published by MDPI AG in Microorganisms
- Vol. 9 (8) , 1621
Open AccessGenome-Wide Expression Patterns of Rhoptry Kinases during the Eimeria tenella Life-Cycle
Kinome from apicomplexan parasites is composed of eukaryotic protein kinases and Apicomplexa specific kinases, such as rhoptry kinases (ROPK). Ropk is a gene family that is known to play important roles in host–pathogen interaction in Toxoplasma gondii but is still poorly described in Eimeria tenella, the parasite responsible for avian coccidiosis worldwide. In the E. tenella genome, 28 ropk genes are predicted and could be classified as active (n = 7), inactive (incomplete catalytic triad, n = 12), and non-canonical kinases (active kinase with a modified catalytic triad, n = 9). We characterized the ropk gene expression patterns by real-time quantitative RT-PCR, normalized by parasite housekeeping genes, during the E. tenella life-cycle. Analyzed stages were: non-sporulated oocysts, sporulated oocysts, extracellular and intracellular sporozoites, immature and mature schizonts I, first- and second-generation merozoites, and gametes. Transcription of all those predicted ropk was confirmed. The mean intensity of transcription was higher in extracellular stages and 7–9 ropk were specifically transcribed in merozoites in comparison with sporozoites. Transcriptional profiles of intracellular stages were closely related to each other, suggesting a probable common role of ROPKs in hijacking signaling pathways and immune responses in infected cells. These results provide a solid basis for future functional analysis of ROPK from E. tenella.